Psychedelics have demonstrated significant progress, generating enthusiasm across the neuroscience industry and leading to ...

Cancerguard, a multi-cancer early detection blood test.

Tesaro confirmed its litigation against AnaptysBio in the Delaware Chancery Court in a press release on its website, ...

Pharmaceutical collaborations expand as Flagship Pioneering expands its partnership with GSK, signing agreements with ...

In today’s Pharmaceutical Executive Daily, learn how Abbott is acquiring Exact Sciences in a major diagnostics deal, Novartis ...

Johnson & Johnson acquires Halda Therapeutics for $3 billion to strengthen its oncology portfolio, focusing on prostate ...

Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...

Moderna's $140 million investment in Norwood, Massachusetts, aims to complete its U.S. manufacturing loop, enhancing ...

UnitedHealth Group appoints Dr. Scott Gottlieb to its board, enhancing leadership amongst a time in which the company looks ...

Just a few weeks after the company announced licensing agreements with Empirico and Syndivia, GSK announced a strategic ...

In the first part of our conversation with Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings ...

Moderna has announced a $140 million investment to enhance its Massachusetts manufacturing capacity, a move that supports ...